Tag: Durvalumab

AstraZeneca reports positive results for phase 2 COAST trial of oleclumab and monalizumab

businessnewstoday- September 18, 2021 0

AstraZeneca has reported positive results from the COAST phase 2 trial of its oleclumab or monalizumab in combination with Imfinzi (durvalumab) in patients with non-small ... Read More

CHMP recommends AstraZeneca lung cancer drug Imfinzi EMA approval

pharmanewsdaily- July 29, 2018 0

Update on Imfinzi EMA approval : The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive ... Read More

FDA lifts clinical hold on Advaxis’ Axalimogene Filolisbac, Durvalumab combo trial

pharmanewsdaily- July 15, 2018 0

Advaxis revealed that the US Food and Drug Administration (FDA) has removed a previously imposed clinical hold on its Phase 1/2 trial of Axalimogene Filolisbac ... Read More